Abbott Laboratories (NYSE: ABT) released its first quarter financial results in an early morning statement, prior to market hours.
The company disclosed quarterly revenues of $10.36 billion, which fell slightly short of Wall Street’s $10.4 billion target.
For the first quarter, Abbott posted adjusted earnings of $1.09 per share, exceeding the consensus estimate of $1.07 profit.
This quarter saw an 11.2 percent increase in earnings and a 4 percent growth in revenue.
Abbott has set an earnings target for Q2 2025 ranging from $1.23 to $1.27 per share, while analysts anticipate earnings of $1.25 per share.
The firm has projected an earnings target for fiscal year 2025 between $5.05 and $5.25 per share, whereas Wall Street analysts predict earnings of $5.15 per share.
